Enhanced Recovery After Surgery (ERAS) protocol in minimally invasive gynecological surgery: a review of the literature.


Journal

Polski przeglad chirurgiczny
ISSN: 2299-2847
Titre abrégé: Pol Przegl Chir
Pays: Poland
ID NLM: 0376426

Informations de publication

Date de publication:
12 Aug 2022
Historique:
entrez: 22 2 2023
pubmed: 23 2 2023
medline: 25 2 2023
Statut: ppublish

Résumé

Enhanced Recovery After Surgery (ERAS) is a complex system of procedures that necessitates multidisciplinary patient care during the preoperative, intraoperative, and postoperative phases. Over the last two decades, the ERAS protocol, which was initially described in colorectal surgery, has gradually expanded to other surgical specialties. Gynecological surgery is no exception, whether for benign or malignant conditions. The ERAS program's primary objective is to overcome the pathophysiological processes associated with surgical stress and to facilitate the patient's rapid recovery, while minimizing complications, hospital stays, and costs. The objectives of minimally invasive surgical procedures largely overlap with the objectives of the ERAS program. We analyzed scientific data from studies examining the ERAS system's application in minimally invasive gynecological surgery (MIGS) and present them in this review. The central question is whether the ERAS protocol can provide additional benefits beyond those inherent in minimally invasive surgical procedures.

Identifiants

pubmed: 36805992
doi: 10.5604/01.3001.0015.8687
pii: 01.3001.0015.8687
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-5

Auteurs

Stanislav Slavchev (S)

Gynecology Clinic in MHAT "St. Anna" - Varna, Department of Obstetrics and Gynecology Faculty of Medicine, Medical University "Prof. Dr. Paraskev Stoyanov" - Varna, Bulgaria.

Angel Yordanov (A)

Department of Gynecologic Oncology, Medical University Pleven, Pleven, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH